Literature DB >> 22511749

Role of RyR2 phosphorylation at S2814 during heart failure progression.

Jonathan L Respress1, Ralph J van Oort, Na Li, Natale Rolim, Sayali S Dixit, Angela deAlmeida, Niels Voigt, William S Lawrence, Darlene G Skapura, Kristine Skårdal, Ulrik Wisløff, Thomas Wieland, Xun Ai, Steven M Pogwizd, Dobromir Dobrev, Xander H T Wehrens.   

Abstract

RATIONALE: Increased activity of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is thought to promote heart failure (HF) progression. However, the importance of CaMKII phosphorylation of ryanodine receptors (RyR2) in HF development and associated diastolic sarcoplasmic reticulum Ca(2+) leak is unclear.
OBJECTIVE: Determine the role of CaMKII phosphorylation of RyR2 in patients and mice with nonischemic and ischemic forms of HF. METHODS AND
RESULTS: Phosphorylation of the primary CaMKII site S2814 on RyR2 was increased in patients with nonischemic, but not with ischemic, HF. Knock-in mice with an inactivated S2814 phosphorylation site were relatively protected from HF development after transverse aortic constriction compared with wild-type littermates. After transverse aortic constriction, S2814A mice did not exhibit pulmonary congestion and had reduced levels of atrial natriuretic factor. Cardiomyocytes from S2814A mice exhibited significantly lower sarcoplasmic reticulum Ca(2+) leak and improved sarcoplasmic reticulum Ca(2+) loading compared with wild-type mice after transverse aortic constriction. Interestingly, these protective effects on cardiac contractility were not observed in S2814A mice after experimental myocardial infarction.
CONCLUSIONS: Our results suggest that increased CaMKII phosphorylation of RyR2 plays a role in the development of pathological sarcoplasmic reticulum Ca(2+) leak and HF development in nonischemic forms of HF such as transverse aortic constriction in mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22511749      PMCID: PMC3371642          DOI: 10.1161/CIRCRESAHA.112.268094

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  31 in total

1.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

2.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

3.  Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction.

Authors:  Hongyu Zhang; Catherine A Makarewich; Hajime Kubo; Wei Wang; Jason M Duran; Ying Li; Remus M Berretta; Walter J Koch; Xiongwen Chen; Erhe Gao; Héctor H Valdivia; Steven R Houser
Journal:  Circ Res       Date:  2012-02-02       Impact factor: 17.367

4.  Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release.

Authors:  Lars S Maier; Tong Zhang; Lu Chen; Jaime DeSantiago; Joan Heller Brown; Donald M Bers
Journal:  Circ Res       Date:  2003-04-03       Impact factor: 17.367

5.  The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.

Authors:  Tong Zhang; Lars S Maier; Nancy D Dalton; Shigeki Miyamoto; John Ross; Donald M Bers; Joan Heller Brown
Journal:  Circ Res       Date:  2003-04-03       Impact factor: 17.367

6.  Expression of Ca2+/calmodulin-dependent protein kinase II delta-subunit isoforms in rats with hypertensive cardiac hypertrophy.

Authors:  D Hagemann; J Bohlender; B Hoch; E G Krause; P Karczewski
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

7.  Oxidation of CaMKII determines the cardiotoxic effects of aldosterone.

Authors:  B Julie He; Mei-Ling A Joiner; Madhu V Singh; Elizabeth D Luczak; Paari Dominic Swaminathan; Olha M Koval; William Kutschke; Chantal Allamargot; Jinying Yang; Xiaoqun Guan; Kathy Zimmerman; Isabella M Grumbach; Robert M Weiss; Douglas R Spitz; Curt D Sigmund; W Matthijs Blankesteijn; Stephane Heymans; Peter J Mohler; Mark E Anderson
Journal:  Nat Med       Date:  2011-11-13       Impact factor: 53.440

8.  Elevated sarcoplasmic reticulum Ca2+ leak in intact ventricular myocytes from rabbits in heart failure.

Authors:  Thomas R Shannon; Steven M Pogwizd; Donald M Bers
Journal:  Circ Res       Date:  2003-08-28       Impact factor: 17.367

9.  Pressure overload selectively up-regulates Ca2+/calmodulin-dependent protein kinase II in vivo.

Authors:  Josep M Colomer; Lan Mao; Howard A Rockman; Anthony R Means
Journal:  Mol Endocrinol       Date:  2003-02

10.  Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.

Authors:  Steven Reiken; Xander H T Wehrens; John A Vest; Alessandro Barbone; Stefan Klotz; Donna Mancini; Daniel Burkhoff; Andrew R Marks
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

View more
  91 in total

Review 1.  Recent Developments in Heart Failure.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Circ Res       Date:  2015-09-11       Impact factor: 17.367

Review 2.  Mechanisms of altered Ca²⁺ handling in heart failure.

Authors:  Min Luo; Mark E Anderson
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 3.  Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death.

Authors:  Stefan Wagner; Lars S Maier; Donald M Bers
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

4.  Calmodulin inhibition of human RyR2 channels requires phosphorylation of RyR2-S2808 or RyR2-S2814.

Authors:  Kafa Walweel; Nieves Gomez-Hurtado; Robyn T Rebbeck; Ye Wint Oo; Nicole A Beard; Peter Molenaar; Cris Dos Remedios; Dirk F van Helden; Razvan L Cornea; Björn C Knollmann; Derek R Laver
Journal:  J Mol Cell Cardiol       Date:  2019-03-27       Impact factor: 5.000

5.  Ryanodine receptor phosphorylation and heart failure: phasing out S2808 and "criminalizing" S2814.

Authors:  Héctor H Valdivia
Journal:  Circ Res       Date:  2012-05-25       Impact factor: 17.367

6.  Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.

Authors:  Michael M Kreusser; Lorenz H Lehmann; Stanislav Keranov; Marc-Oscar Hoting; Ulrike Oehl; Michael Kohlhaas; Jan-Christian Reil; Kay Neumann; Michael D Schneider; Joseph A Hill; Dobromir Dobrev; Christoph Maack; Lars S Maier; Hermann-Josef Gröne; Hugo A Katus; Eric N Olson; Johannes Backs
Journal:  Circulation       Date:  2014-08-14       Impact factor: 29.690

Review 7.  Cardiac aging and heart disease in humans.

Authors:  Marja Steenman; Gilles Lande
Journal:  Biophys Rev       Date:  2017-03-20

8.  Targeted antioxidant treatment decreases cardiac alternans associated with chronic myocardial infarction.

Authors:  Bradley N Plummer; Haiyan Liu; Xiaoping Wan; Isabelle Deschênes; Kenneth R Laurita
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-09

Review 9.  Regulating the regulator: Insights into the cardiac protein phosphatase 1 interactome.

Authors:  David Y Chiang; Albert J R Heck; Dobromir Dobrev; Xander H T Wehrens
Journal:  J Mol Cell Cardiol       Date:  2016-09-20       Impact factor: 5.000

10.  Aberrant S-nitrosylation mediates calcium-triggered ventricular arrhythmia in the intact heart.

Authors:  Michael J Cutler; Bradley N Plummer; Xiaoping Wan; Qi-An Sun; Douglas Hess; Haiyan Liu; Isabelle Deschenes; David S Rosenbaum; Jonathan S Stamler; Kenneth R Laurita
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.